Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Carbohydrate doai
Patent
1997-10-13
2000-09-26
Fonda, Kathleen K.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Carbohydrate doai
514 2, 536 20, A61K 3173
Patent
active
06124273&
ABSTRACT:
This invention is directed to the preparation and utilization of supplemented chitin hydrogels, such as chitosan hydrogels. Further provided are biomaterials comprising same. The particular supplement delivered by the chitin hydrogel is selected as a function of its intended use. In one embodiment, this invention provides a composition of matter, comprising a chitin hydrogel or chitin-derived hydrogel, wherein the hydrogel does not inhibit full-thickness skin wound healing.
REFERENCES:
patent: Re33375 (1990-10-01), Luck et al.
patent: 4424346 (1984-01-01), Hall et al.
patent: 4570629 (1986-02-01), Widra
patent: 4619995 (1986-10-01), Hayes
patent: 4659700 (1987-04-01), Jackson
patent: 4868113 (1989-09-01), Jaye et al.
patent: 4886787 (1989-12-01), de Belder et al.
patent: 4978332 (1990-12-01), Luck et al.
patent: 5080893 (1992-01-01), Goldberg et al.
patent: 5093319 (1992-03-01), Higham et al.
patent: 5234915 (1993-08-01), Mathur et al.
patent: 5460939 (1995-10-01), Hansbrough et al.
patent: 5470829 (1995-11-01), Prisell et al.
patent: 5510102 (1996-04-01), Cochrum
patent: 5679658 (1997-10-01), Elson
Adelmann-Grill, B. C. et al., "Chemotactic migration of normal dermal fibroblasts towards epidermal growth factor and its modulation by platelet-derived growth factor and transforming growth factor-beta," Eur. J. Cell Biol. 51(2):322-326 (Apr. 1990).
Buchholz, H. W. et al., "Management of Deep Infection of Total Hip Replacement," J. Bone and Joint Surgery 63-B(3):342-353 (1981).
Buchholz, H. W. et al., "Antibiotic-loaded Acrylic Cement: Current Concepts," Clin. Orthop. Rel. Res. 190:96-108 (Nov. 1984).
Burgess, W. H. and T. Maciag, "The Heparin-Binding (Fibroblast) Growth Factor Family of Proteins," Annu. Rev. Biochem 58:575-606 (1989).
Canalis, E. et al., "Growth Factors and the Regulation of Bone Remodeling," J. Clin. Invest. 81(2):277-281 (Feb. 1988).
Chandrasekaran, S. K. and D. R. Paul, "Dissolution-Controlled Transport from Dispersed Matrixes," J. Pharm. Sci. 71(12):1399-1402 (Dec. 1982).
Chandy, T. and C. P. Sharma, "Biodegradable Chitosan Matrix for the Controlled Release of Steroids," Biomat., Art. Cells & Immob. Biotech. 19(14):745-760 (1991).
Christian, E. P. et al., "Reconstruction of Large Diaphyseal Defects, without Free Fibular Transfer, in Grade-IIIB Tibial Fractures," J. Bone Joint Surgery 71-A(7):994-1004 (Aug. 1989).
Dash, A. K, and R. Suryanarayanan, "An Implantable Dosage Form for the Treatment of Bone Infections," Pharm. Res. 9(8):993-1002 (Aug. 1992).
Golub, L. M. et al., "Treating Periodontal Diseases by Blocking Tissue-Destructive Enzymes," J. Amer. Dent. Assoc. 125:163-171 (Feb. 1994).
Goodson, J. M. et al., "Monolithic Tetracycline-containing Fibers for Controlled Delivery to Periodontal Pockets," J. Periodontol. 54(10):575-579 (Oct. 1983).
Gospodarowicz, D. et al., "Fibroblast growth factor," Mol. Cell. Endocrinol. 46(3):187-204 (1986).
Gospodarowicz, D. et al., "Structural Characterization and Biological Functions of Fibroblast Growth Factor," Endocrine Rev. 8(2):95-114 (1987).
Greco, F. et al., "Fibrin-antibiotic mixtures: An in vitro study assessing the possibility of using a biologic carrier for local drug delivery," J. Biomed. Mat. Res. 25(1):39-51 (Jan. 1991).
Greenhalgh, D. G. et al., "PDGF and FGF Stimulate Wound Healing in the Genetically Diabetic Mouse," Amer. J. Pathol. 136(6):1235-1246 (Jun. 1990).
Gristina, A. G. et al., "Bacteria and Biomaterials," in: Implantation Biology: The Host Response and Biomedical Devices, Greco, R. S., ed., Boca Raton, FA: CRC Press, pp. 131-148 (Mar. 1994).
Hattori, T., "Experimental Investigations of Osteogenesis and Chondrogenesis by Implant of BMP-Fibrin Glue Mixture," J. Jpn. Orthop. Assoc. 64(9):824-834 (Sep. 1990).
Hauschka, P. V. et al., "Growth Factors in Bone Matrix: Isolation of Multiple Types by Affinity Chromatography on Heparin-Sepharose," J. Biol. Chem. 261(27):12665-12674 (Sep. 1986).
Hayek, A. et al., "An In Vivo Model for Study of the Angiogenic Effects of Basic Fibroblast Growth Factor," Biochem. Biophys. Res. Comm. 147(2):876-880 (Sep. 1987).
Higuchi, T., "Mechanism of Sustained-Action Medication: Theroetical Analysis of Rate of Release of Solid Drugs Disperesed in Solid Matrices," J. Pharm. Sci. 52(12):1145-1149 (Dec. 1963).
Jaye, M. et al., "Biological Equivalence of Natural Bovine and Recombinant Human .alpha.-Endothelial Cell Growth Factors," J. Biol. Chem. 262(34):16612-16617 (Dec. 1987).
Kawamura, M. and M. R. Urist, "Human Fibrin Is a Physiological Delivery System for Bone Morphogenetic Protein," Clin. Orthop. Rel. Res. 235:302-310 (Oct. 1988).
Klokkevold, P. R. et al., "Effect of Chitosan on Lingual Hemostasis in Rabbits With Platelet Dysfunction Induced by Epoprostenol," J. Oral. Maxillofac. Surg. 50(1):41-45 (Jan. 1992).
Knighton, D. R. et al., "Classification and Treatment of Chronic Nonhealing Wounds:Successful Treatment with Autologous Platelet-dervived Wound Healing Factors (PDWHF)," Ann. Surg. 204(3):322-330 (Sep. 1986).
Kram, H. B. et al., "Antibacterial Effects of Fibrin Glue-Antibiotic Mixtures," J. Surg. Res. 50(2):175-178 (Feb. 1991).
Fristl, J. et al., "Hydrocolloids and gels of chitosan as drug carriers," Int. J. Pharm. 99:13-19 (1993).
Ksander, G. A. et al., "The effect of platelet releasate on wound healing in animal models," J. Amer. Acad. Dermatol. 22(5):781-791 (May 1990).
Lynch, S. E. et al., "Growth Factors in Wound Healing: Single and Synergistic Effects on Partial Thickness Porcine Skin Wounds," J. Clin. Invest. 84(2):640-646 (Aug. 1989).
Stiles, C. D. et al., "Dual control of cell growth by somatomedins and platelet-derived growth factor," Proc. Natl. Acad. Sci. USA 76(3):1279-1283 (Mar. 1979).
Luyten, F. P. et al., "Purification and Partial Amno Acid Sequence of Osteogenin, a Protein Initiating Bone Differentiation," J. Biol. Chem. 264(23):13377-13380 (Aug. 1989).
Mackey, D. et al., "Antibiotic Loaded Plaster of Paris Pellets: An In vitro Study of a Possible Method of Local Antibiotic Therapy in Bone Infection," Clin. Orthop. Rel. Res. 167:263-268 (Jul. 1982).
Majid, S. A. et al., "Gentamicin-PMMA beads in the treatment of chronic osteomyelitis," Acta Orthop. Scand. 56(3):265-268 (Jun. 1985).
Menache, D. et al., "Coagulation Factor IX (human)," in: Hemophilia and Von Willebrand's Disease in the 1990's: A New Decade of Hopes and Challenges, Lusher, J. M. and C. M. Kessler, eds., Amsterdam: Elsevier Science Publishers B. V., pp. 301-305 (1991).
Miclau, T. et al., "In Vitro Pharmocokinetics of Antibiotic Release from Locally Implantable Materials," J. Orthop. Res. 11(5):627-653 (1993).
Piszkiewicz, D. et al., "Inactivation of HIV in antithrombin-III concentrate by pasteurization," Transfusion 28(2):198-199 (1988).
Puumala, M. et al., "Intraventicular infusion of HBGF-2 promotes cerebral angiogenesis in Wistar rat," Brain Res. 534(1/2):283-286 (1990).
Rath, N. C. and A. H. Reddi, "Collagenous bone matrix is a local mitogen," Nature 278:855-857 (Apr. 1979).
Redl, H. et al., "In vitro properties of mixtures of fibrin seal and antibiotics," Biomat. 4(1):29-32 (Jan. 1983).
Sakurai, T. et al., "Controlled release of sisomicin from fibrin glue," J. Controlled Rel. 18(1):39-43 (1992).
Schlag, G. and H. Redl, "Fibrin Sealent in Orthopedic Surgery," Clin. Orthop. Rel. Res. 227:269-285 (Feb. 1988).
Schultz, G. S. et al., "Epithelial Wound Healing Enhanced by Transforming Growth Factor-.alpha. and Vaccinia Growth Factor," Science 235:350-235 (Jan. 1987).
Schrenk, P. et al., "Fibrin Glue Coating of e-PTFE Prostheses Enhances Seeding of Human Endothelial Cells," Thorac. Cardiovasc. Surgeon 35(1):6-10 (Feb. 1987).
Schwarz, N. et al., "The Influence of Fibrin Sealant on Demineralized Bone Matrix-Dependent Osteoinduction," Clin. Orthop. Rel. Res. 238:282-287 (Jan. 1989).
Tabor, E. et al., "Inactivation of Hepatitis B Virus by Heat in Antithrombin III Stabilized with Citrate," Thromb. Res. 22(1/2):233-238 (1981).
Thacharodi, D. and K. Panduranga Rao, "Release of nifedipine through crosslinked chitosan membranes," Int. J. Pharm. 96(1-3):33-39 (Jul. 1993).
Thompson, J. A. et al., "Si
Drohan William N.
Elson Clive
MacPhee Martin J.
Miekka Shirley I.
Singh Manish S.
Chitogenics, Inc.
Coalition for Hemophilia B
Fonda Kathleen K.
The American National Red Cross
LandOfFree
Chitin hydrogels, methods of their production and use does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Chitin hydrogels, methods of their production and use, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Chitin hydrogels, methods of their production and use will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2100289